Insider Selling: Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) CFO Sells 50,360 Shares of Stock

Share on StockTwits

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) CFO Dennis Olis sold 50,360 shares of the firm’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $9.01, for a total transaction of $453,743.60. Following the completion of the transaction, the chief financial officer now directly owns 332,643 shares of the company’s stock, valued at $2,997,113.43. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

NASDAQ MDRX opened at $9.13 on Thursday. Allscripts Healthcare Solutions Inc has a 52-week low of $8.50 and a 52-week high of $12.40. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.66 and a current ratio of 0.66. The company has a market capitalization of $1.48 billion, a P/E ratio of 7.80, a P/E/G ratio of 1.64 and a beta of 1.39. The company has a fifty day moving average of $9.36 and a 200-day moving average of $10.03.

Several hedge funds and other institutional investors have recently bought and sold shares of MDRX. Carroll Financial Associates Inc. bought a new stake in shares of Allscripts Healthcare Solutions during the 4th quarter worth $36,000. Robeco Institutional Asset Management B.V. bought a new stake in shares of Allscripts Healthcare Solutions during the 3rd quarter worth $106,000. Virtu Financial LLC bought a new stake in shares of Allscripts Healthcare Solutions during the 4th quarter worth $106,000. Tower Research Capital LLC TRC lifted its holdings in shares of Allscripts Healthcare Solutions by 781.0% during the 4th quarter. Tower Research Capital LLC TRC now owns 11,480 shares of the software maker’s stock worth $113,000 after acquiring an additional 10,177 shares during the last quarter. Finally, NumerixS Investment Technologies Inc lifted its holdings in shares of Allscripts Healthcare Solutions by 98.9% during the 4th quarter. NumerixS Investment Technologies Inc now owns 18,500 shares of the software maker’s stock worth $182,000 after acquiring an additional 9,200 shares during the last quarter.

Several research analysts have commented on MDRX shares. UBS Group started coverage on shares of Allscripts Healthcare Solutions in a report on Tuesday, November 26th. They issued a “neutral” rating and a $11.50 price target for the company. BidaskClub downgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “strong sell” rating in a report on Tuesday, December 17th. Zacks Investment Research raised shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and set a $11.00 price target for the company in a report on Tuesday, December 3rd. ValuEngine raised shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Monday, December 30th. Finally, Cantor Fitzgerald reissued a “neutral” rating on shares of Allscripts Healthcare Solutions in a report on Tuesday, November 5th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. Allscripts Healthcare Solutions has an average rating of “Hold” and a consensus target price of $11.63.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Further Reading: Risk Tolerance

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Alpine Woods Capital Investors LLC Trims Stake in Alpine Immune Sciences Inc
Alpine Woods Capital Investors LLC Trims Stake in Alpine Immune Sciences Inc
American International Group Inc. Increases Stock Holdings in Check Point Software Technologies Ltd.
American International Group Inc. Increases Stock Holdings in Check Point Software Technologies Ltd.
Fortune Brands Home & Security Inc  Shares Purchased by American International Group Inc.
Fortune Brands Home & Security Inc Shares Purchased by American International Group Inc.
American International Group Inc. Sells 1,922 Shares of Discovery Communications Inc.
American International Group Inc. Sells 1,922 Shares of Discovery Communications Inc.
American International Group Inc. Increases Stock Position in Federal Realty Investment Trust
American International Group Inc. Increases Stock Position in Federal Realty Investment Trust
American International Group Inc. Grows Stock Holdings in ACADIA Pharmaceuticals Inc.
American International Group Inc. Grows Stock Holdings in ACADIA Pharmaceuticals Inc.


 
© 2006-2020 Zolmax.